Velocity Clinical Research - MedPharmics - Lafayette

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 2	2026-10-09	NCT06672055
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)	Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Primary Immunodeficiency Diseases, agammaglobulinemia, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome	Active, not recruiting	Phase 3	2026-05-29	NCT04944979
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature	Idiopathic Short Stature	Recruiting	Phase 2	2026-05-22	NCT06382155

Clinical trials